1. Home
  2. FTK vs ENTA Comparison

FTK vs ENTA Comparison

Compare FTK & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$14.04

Market Cap

445.8M

Sector

Industrials

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.94

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
ENTA
Founded
1985
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
445.8M
407.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
FTK
ENTA
Price
$14.04
$13.94
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$16.00
$20.33
AVG Volume (30 Days)
369.7K
298.3K
Earning Date
11-04-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
242.12
N/A
EPS
0.93
N/A
Revenue
$220,501,000.00
$65,324,000.00
Revenue This Year
$19.47
$2.13
Revenue Next Year
$11.29
$2.74
P/E Ratio
$15.28
N/A
Revenue Growth
23.56
N/A
52 Week Low
$6.05
$4.09
52 Week High
$18.96
$15.34

Technical Indicators

Market Signals
Indicator
FTK
ENTA
Relative Strength Index (RSI) 43.11 70.25
Support Level $13.75 $11.89
Resistance Level $14.67 $14.51
Average True Range (ATR) 0.80 0.86
MACD -0.07 0.15
Stochastic Oscillator 34.00 80.34

Price Performance

Historical Comparison
FTK
ENTA

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: